9US2
Crystal structure of YgdH from Neisseria meningitidis
9US2 の概要
| エントリーDOI | 10.2210/pdb9us2/pdb |
| 分子名称 | Cytokinin riboside 5'-monophosphate phosphoribohydrolase, CITRIC ACID (3 entities in total) |
| 機能のキーワード | cytokinin riboside 5'-monophosphate phosphoribohydrolase with a strong preference for ump, hydrolase |
| 由来する生物種 | Neisseria meningitidis |
| タンパク質・核酸の鎖数 | 3 |
| 化学式量合計 | 68330.33 |
| 構造登録者 | |
| 主引用文献 | Yu, L.,Chen, R.,Zhang, C.,Wang, Z.,Wang, Z.,Zeng, X.,Liang, H.,He, Y.,She, Y.,Wang, Y.,Gong, R.,Song, X.,Deng, Z.,Fei, Q.,Chen, W. A combined pseudouridine biomanufacturing platform enabled by a streamlined designer pathway. Nat Commun, 16:8866-8866, 2025 Cited by PubMed Abstract: mRNA vaccines, featured by incorporated pseudouridine (Ψ), represent a milestone in combating diseases, thus highlighting Ψ importance in drug development. However, economic and environmental challenges have persisted in sustainable Ψ production. Here, we formulate a streamlined designer Ψ pathway, comprising UMP nucleosidase, ΨMP glycosidase, and ΨMP phosphatase, and realize its gram-scale production by targeted discovery of a prominent UMP-preferred nucleosidase (NmYgdH). The optimized pathway, containing NmYgdH, RjPsuG (ΨMP glycosidase), and HDHD1 (ΨMP-specific phosphatase) is cloned into E. coli and systematic evaluation of multiple strategies achieves a Ψ titer of 44.8 g·L. Moreover, a thyA-dependent, tunable, and eco-friendly strategy for sustainable Ψ production is demonstrated in a 5 L bioreactor achieving titer of 45.3 g·L. Finally, we establish a simplified-strategy for rapid Ψ purification with a recovery-rate of 71%, and techno-economic analysis is employed to validate the feasibility and advantages of this fermentation platform for Ψ biomanufacturing. Therefore, this study provides a blueprint for industrial-production of nucleoside-related molecules. PubMed: 41053063DOI: 10.1038/s41467-025-63906-0 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.8 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






